(ACN) Accenture - Overview
Exchange: NYSE •
Country: Ireland •
Currency: USD •
Type: Common Stock •
ISIN: IE00B4BNMY34
Stock:
Total Rating 48
Risk 94
Buy Signal -0.64
| Risk 5d forecast | |
|---|---|
| Volatility | 44.2% |
| Relative Tail Risk | -7.31% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.50 |
| Alpha | -52.77 |
| Character TTM | |
|---|---|
| Beta | 0.651 |
| Beta Downside | 0.223 |
| Drawdowns 3y | |
|---|---|
| Max DD | 50.83% |
| CAGR/Max DD | -0.13 |
EPS (Earnings per Share)
Revenue
Description: ACN Accenture
Accenture plc provides strategy and consulting, industry X, song, and technology and operation services in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It offers systems integration and application management; security; intelligent platform; infrastructure; software engineering; data, AI, cloud; and automation and global delivery services. The company also operates business processes for specific enterprise functions, including finance and accounting, sourcing and procurement, supply chain, marketing and sales, and human resources, as well as industry-specific services, such as platform trust and safety, banking, insurance, network and health services; and designs, manufactures, and assembles automation equipment, robotics, and other commercial hardware products. It serves communications, media, and technology; financial services; banking and capital markets, and insurance; health and public service; consumer goods, retail, travel services; industrial; life science; and chemicals, natural resources, energy, and utilities sectors. Accenture plc has collaboration with Amazon Web Services (AWS) to deliver transformative digital services to public sector, defense, and national security organizations. It has a collaboration with OpenAI to help enterprise clients unlock new levels of innovation and growth by bringing agentic AI systems. Accenture plc was founded in 1951 and is based in Dublin, Ireland.
Piotroski VR‑10 (Strict, 0-10) 8.5
| Net Income: 7.61b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.18 > 0.02 and ΔFCF/TA 2.67 > 1.0 |
| NWC/Revenue: 11.55% < 20% (prev 12.07%; Δ -0.52% < -1%) |
| CFO/TA 0.19 > 3% & CFO 12.12b > Net Income 7.61b |
| Net Debt (-1.45b) to EBITDA (12.34b): -0.12 < 3 |
| Current Ratio: 1.41 > 1.5 & < 3 |
| Outstanding Shares: last quarter (626.0m) vs 12m ago -1.36% < -2% |
| Gross Margin: 31.93% > 18% (prev 0.32%; Δ 3160 % > 0.5%) |
| Asset Turnover: 113.6% > 50% (prev 110.8%; Δ 2.71% > 0%) |
| Interest Coverage Ratio: 39.97 > 6 (EBITDA TTM 12.34b / Interest Expense TTM 263.9m) |
Altman Z'' 3.74
| A: 0.13 (Total Current Assets 28.07b - Total Current Liabilities 19.90b) / Total Assets 64.70b |
| B: 0.34 (Retained Earnings 22.15b / Total Assets 64.70b) |
| C: 0.17 (EBIT TTM 10.55b / Avg Total Assets 62.28b) |
| D: 0.63 (Book Value of Equity 20.55b / Total Liabilities 32.78b) |
| Altman-Z'' Score: 3.74 = AA |
Beneish M -3.02
| DSRI: 1.03 (Receivables 16.01b/14.57b, Revenue 70.73b/66.36b) |
| GMI: 1.02 (GM 31.93% / 32.47%) |
| AQI: 0.98 (AQ_t 0.50 / AQ_t-1 0.51) |
| SGI: 1.07 (Revenue 70.73b / 66.36b) |
| TATA: -0.07 (NI 7.61b - CFO 12.12b) / TA 64.70b) |
| Beneish M-Score: -3.02 (Cap -4..+1) = AA |
What is the price of ACN shares?
As of February 28, 2026, the stock is trading at USD 208.72 with a total of 7,927,446 shares traded.
Over the past week, the price has changed by -3.08%, over one month by -24.32%, over three months by -16.02% and over the past year by -40.20%.
Over the past week, the price has changed by -3.08%, over one month by -24.32%, over three months by -16.02% and over the past year by -40.20%.
Is ACN a buy, sell or hold?
Accenture has received a consensus analysts rating of 4.15.
Therefore, it is recommended to buy ACN.
- StrongBuy: 12
- Buy: 6
- Hold: 8
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the ACN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 288.6 | 38.3% |
| Analysts Target Price | 288.6 | 38.3% |
ACN Fundamental Data Overview February 28, 2026
P/E Trailing = 15.8185
P/E Forward = 16.0256
P/S = 1.8184
P/B = 3.8181
P/EG = 1.705
Revenue TTM = 70.73b USD
EBIT TTM = 10.55b USD
EBITDA TTM = 12.34b USD
Long Term Debt = 5.03b USD (from longTermDebt, last quarter)
Short Term Debt = 842.9m USD (from shortTermDebt, last quarter)
Debt = 8.20b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.45b USD (from netDebt column, last quarter)
Enterprise Value = 127.16b USD (128.60b + Debt 8.20b - CCE 9.65b)
Interest Coverage Ratio = 39.97 (Ebit TTM 10.55b / Interest Expense TTM 263.9m)
EV/FCF = 11.05x (Enterprise Value 127.16b / FCF TTM 11.51b)
FCF Yield = 9.05% (FCF TTM 11.51b / Enterprise Value 127.16b)
FCF Margin = 16.28% (FCF TTM 11.51b / Revenue TTM 70.73b)
Net Margin = 10.76% (Net Income TTM 7.61b / Revenue TTM 70.73b)
Gross Margin = 31.93% ((Revenue TTM 70.73b - Cost of Revenue TTM 48.15b) / Revenue TTM)
Gross Margin QoQ = 32.91% (prev 31.89%)
Tobins Q-Ratio = 1.97 (Enterprise Value 127.16b / Total Assets 64.70b)
Interest Expense / Debt = 0.80% (Interest Expense 65.4m / Debt 8.20b)
Taxrate = 24.46% (725.8m / 2.97b)
NOPAT = 7.97b (EBIT 10.55b * (1 - 24.46%))
Current Ratio = 1.41 (Total Current Assets 28.07b / Total Current Liabilities 19.90b)
Debt / Equity = 0.27 (Debt 8.20b / totalStockholderEquity, last quarter 30.87b)
Debt / EBITDA = -0.12 (Net Debt -1.45b / EBITDA 12.34b)
Debt / FCF = -0.13 (Net Debt -1.45b / FCF TTM 11.51b)
Total Stockholder Equity = 30.47b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.22% (Net Income 7.61b / Total Assets 64.70b)
RoE = 24.98% (Net Income TTM 7.61b / Total Stockholder Equity 30.47b)
RoCE = 29.71% (EBIT 10.55b / Capital Employed (Equity 30.47b + L.T.Debt 5.03b))
RoIC = 22.37% (NOPAT 7.97b / Invested Capital 35.62b)
WACC = 7.85% (E(128.60b)/V(136.81b) * Re(8.31%) + D(8.20b)/V(136.81b) * Rd(0.80%) * (1-Tc(0.24)))
Discount Rate = 8.31% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.89%
[DCF] Terminal Value 79.45% ; FCFF base≈10.53b ; Y1≈11.14b ; Y5≈13.20b
[DCF] Fair Price = 387.1 (EV 236.77b - Net Debt -1.45b = Equity 238.22b / Shares 615.4m; r=7.85% [WACC]; 5y FCF grow 6.37% → 2.90% )
EPS Correlation: 62.96 | EPS CAGR: 12.42% | SUE: 2.85 | # QB: 1
Revenue Correlation: 86.86 | Revenue CAGR: 6.03% | SUE: 0.92 | # QB: 3
EPS next Quarter (2026-05-31): EPS=3.70 | Chg7d=+0.000 | Chg30d=+0.001 | Revisions Net=+0 | Analysts=21
EPS current Year (2026-08-31): EPS=13.84 | Chg7d=+0.021 | Chg30d=+0.019 | Revisions Net=+14 | Growth EPS=+7.0% | Growth Revenue=+6.0%
EPS next Year (2027-08-31): EPS=14.92 | Chg7d=+0.023 | Chg30d=+0.029 | Revisions Net=+6 | Growth EPS=+7.8% | Growth Revenue=+5.6%
[Analyst] Revisions Ratio: +0.00 (10 Up / 10 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 2.0% (Discount Rate 8.3% - Earnings Yield 6.3%)
[Growth] Growth Spread = +3.5% (Analyst 5.4% - Implied 2.0%)
P/E Forward = 16.0256
P/S = 1.8184
P/B = 3.8181
P/EG = 1.705
Revenue TTM = 70.73b USD
EBIT TTM = 10.55b USD
EBITDA TTM = 12.34b USD
Long Term Debt = 5.03b USD (from longTermDebt, last quarter)
Short Term Debt = 842.9m USD (from shortTermDebt, last quarter)
Debt = 8.20b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.45b USD (from netDebt column, last quarter)
Enterprise Value = 127.16b USD (128.60b + Debt 8.20b - CCE 9.65b)
Interest Coverage Ratio = 39.97 (Ebit TTM 10.55b / Interest Expense TTM 263.9m)
EV/FCF = 11.05x (Enterprise Value 127.16b / FCF TTM 11.51b)
FCF Yield = 9.05% (FCF TTM 11.51b / Enterprise Value 127.16b)
FCF Margin = 16.28% (FCF TTM 11.51b / Revenue TTM 70.73b)
Net Margin = 10.76% (Net Income TTM 7.61b / Revenue TTM 70.73b)
Gross Margin = 31.93% ((Revenue TTM 70.73b - Cost of Revenue TTM 48.15b) / Revenue TTM)
Gross Margin QoQ = 32.91% (prev 31.89%)
Tobins Q-Ratio = 1.97 (Enterprise Value 127.16b / Total Assets 64.70b)
Interest Expense / Debt = 0.80% (Interest Expense 65.4m / Debt 8.20b)
Taxrate = 24.46% (725.8m / 2.97b)
NOPAT = 7.97b (EBIT 10.55b * (1 - 24.46%))
Current Ratio = 1.41 (Total Current Assets 28.07b / Total Current Liabilities 19.90b)
Debt / Equity = 0.27 (Debt 8.20b / totalStockholderEquity, last quarter 30.87b)
Debt / EBITDA = -0.12 (Net Debt -1.45b / EBITDA 12.34b)
Debt / FCF = -0.13 (Net Debt -1.45b / FCF TTM 11.51b)
Total Stockholder Equity = 30.47b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.22% (Net Income 7.61b / Total Assets 64.70b)
RoE = 24.98% (Net Income TTM 7.61b / Total Stockholder Equity 30.47b)
RoCE = 29.71% (EBIT 10.55b / Capital Employed (Equity 30.47b + L.T.Debt 5.03b))
RoIC = 22.37% (NOPAT 7.97b / Invested Capital 35.62b)
WACC = 7.85% (E(128.60b)/V(136.81b) * Re(8.31%) + D(8.20b)/V(136.81b) * Rd(0.80%) * (1-Tc(0.24)))
Discount Rate = 8.31% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.89%
[DCF] Terminal Value 79.45% ; FCFF base≈10.53b ; Y1≈11.14b ; Y5≈13.20b
[DCF] Fair Price = 387.1 (EV 236.77b - Net Debt -1.45b = Equity 238.22b / Shares 615.4m; r=7.85% [WACC]; 5y FCF grow 6.37% → 2.90% )
EPS Correlation: 62.96 | EPS CAGR: 12.42% | SUE: 2.85 | # QB: 1
Revenue Correlation: 86.86 | Revenue CAGR: 6.03% | SUE: 0.92 | # QB: 3
EPS next Quarter (2026-05-31): EPS=3.70 | Chg7d=+0.000 | Chg30d=+0.001 | Revisions Net=+0 | Analysts=21
EPS current Year (2026-08-31): EPS=13.84 | Chg7d=+0.021 | Chg30d=+0.019 | Revisions Net=+14 | Growth EPS=+7.0% | Growth Revenue=+6.0%
EPS next Year (2027-08-31): EPS=14.92 | Chg7d=+0.023 | Chg30d=+0.029 | Revisions Net=+6 | Growth EPS=+7.8% | Growth Revenue=+5.6%
[Analyst] Revisions Ratio: +0.00 (10 Up / 10 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 2.0% (Discount Rate 8.3% - Earnings Yield 6.3%)
[Growth] Growth Spread = +3.5% (Analyst 5.4% - Implied 2.0%)